Porton Pharma Solutions Ltd. (SHE:300363)
China · Delayed Price · Currency is CNY 15.63
-0.24 (-1.51%)
Jul 29, 2026, 3:07 PM CST
Porton Pharma Solutions Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,505 | 3,420 | 3,012 | 3,667 | 7,035 | 3,105 |
Revenue Growth | 11.78% | 13.54% | -17.87% | -47.87% | 126.55% | 49.87% |
Gross Profit Gross Profit Growth | 1,056 | 995.37 | 702.62 | 1,437 | 3,636 | 1,262 |
Operating Income Operating Income Growth | 158.06 | 128.11 | -224 | 291.88 | 2,218 | 555.88 |
Net Income Net Income Growth | 128.49 | 96.34 | -287.75 | 266.86 | 2,005 | 523.92 |
Earnings Per Share EPS Growth | 0.23 | 0.18 | -0.53 | 0.49 | 3.69 | 0.97 |
EPS Growth | - | - | - | -86.72% | 280.41% | 61.67% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Small Molecule Api Business Small Molecule Api Business Growth | 3,092 | 2,740 | 3,467 | - | - |
Emerging Business Emerging Business Growth | 304.96 | 242.56 | 180.02 | - | - |
Other Operations Other Operations Growth | 22.98 | 29.8 | 20.72 | 79.13 | 15.75 |
Total Total Growth | 3,420 | 3,012 | 3,667 | 7,035 | 3,105 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,346 | 1,411 | 1,475 | 1,967 | 2,850 | 1,217 |
Total Debt Total Debt Growth | 1,488 | 1,510 | 1,956 | 1,973 | 923.77 | 740.77 |
Net Cash (Debt) Net Cash Growth | -142.48 | -99.74 | -481.6 | -6.61 | 1,927 | 476.1 |
Net Cash Growth | - | - | - | - | 304.68% | -53.09% |
Net Cash Per Share Net Cash Per Share Growth | -0.25 | -0.19 | -0.89 | -0.01 | 3.55 | 0.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 673.79 | 757.01 | 405.53 | 629.06 | 2,564 | 480.17 |
Capital Expenditures CapEx Growth | -201.7 | -292.57 | -490.58 | -1,130 | -1,173 | -776.97 |
Free Cash Flow Free Cash Flow Growth | 472.09 | 464.45 | -85.06 | -500.81 | 1,391 | -296.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 30.12% | 29.11% | 23.33% | 39.19% | 51.69% | 40.64% |
Operating Margin | 4.51% | 3.75% | -7.44% | 7.96% | 31.52% | 17.90% |
Pretax Margin | 3.07% | 2.42% | -12.42% | 6.72% | 31.92% | 17.67% |
Profit Margin | 3.67% | 2.82% | -9.55% | 7.28% | 28.51% | 16.87% |
FCF Margin | 13.47% | 13.58% | -2.82% | -13.66% | 19.78% | -9.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.090 | 0.090 | - | 0.487 | 1.106 | 0.193 |
Dividend Per Share Growth | 0% | - | - | -55.97% | 473.06% | 59.50% |
Dividend Yield | 0.57% | 0.39% | - | 2.01% | 2.90% | 0.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 69.03 | 130.30 | - | 51.47 | 11.12 | 92.95 |
Forward PE | 42.24 | 68.76 | 54.14 | 27.07 | 12.63 | 71.85 |
P/FCF Ratio | 17.95 | 27.03 | - | - | 16.03 | - |
PS Ratio | 2.42 | 3.67 | 2.86 | 3.75 | 3.17 | 15.68 |